Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

When de-extinction startup Colossal Biosciences revealed last year that it was attempting to “resurrect” the dire wolf from genetic material found in fossils, we argued that, despite the controversy s...